Menopausal hormone replacement therapy may be part of a health promotion plan

Menopausal hormone replacement therapy is the use of estrogen and progesterone to support the decline of these hormones through perimenopause and postmenopause. This was used very regularly for women until a big study in the 90s that showed concerning risks.

 In more recent research and analyses of that 30 year old data however, it’s been realized that in certain populations of women (especially those early post-menopause, without major heart health risks) it can actually be a very supportive therapy and can be protective for:

- Heart Health

- Diabetes prevention

- Bone density

It is also an effective tool to manage:

- Hot flashes

- Isomnia

- Mood

- Sexual function

- Vaginal/urinary health 

and other common symptoms post-menopause. 

The average age of menopause in Canada has not changed at 51 years old, but our lifespan has changed significantly.  In 1921 the lifespan was about 56 years old, whereas now it’s closer to 84 years old. Many women are spending 30+ years post menopause, where it used to be 5 years. 30+ years without estrogen production has significant implications!

Hormone replacement therapy is not the ONLY strategy for supporting health in perimenopause and post menopause, but it absolutely should be PART of the conversation in supporting women through this phase of life.

For some it will provide great benefit and prevent certain diseases, whereas for others it may increase certain risks.

There are a variety of different types of hormone replacement therapy, with different risk/benefit profiles depending on one’s health concerns and family history. 

If you feel this should be part of your health plan, or even if you’re not sure, please talk to a practitioner like myself that is well-versed on the options.